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Abstract
Background: The β3 subunit of the γ-aminobutyric acid type A receptor (GABAA-R) has been
reported to be important for palate formation, anesthetic action, and normal nervous system
function. This subunit has also been implicated in the pathogenesis of Angelman syndrome and
autism spectrum disorder. To further investigate involvement of this subunit, we previously
produced mice with a global knockout of β3. However, developmental abnormalities,
compensation, reduced viability, and numerous behavioral abnormalities limited the usefulness of
that murine model. To overcome many of these limitations, a mouse line with a conditionally
inactivated β3 gene was engineered.
Results: Gene targeting and embryonic stem cell technologies were used to create mice in which
exon 3 of the β3 subunit was flanked by loxP sites (i.e., floxed). Crossing the floxed β3 mice to a
cre general deleter mouse line reproduced the phenotype of the previously described global
knockout. Pan-neuronal knockout of β3 was achieved by crossing floxed β3 mice to Synapsin I-cre
transgenic mice. Palate development was normal in pan-neuronal β3 knockouts but ~61% died as
neonates. Survivors were overtly normal, fertile, and were less sensitive to etomidate. Forebrain
selective knockout of β3 was achieved using α CamKII-cre transgenic mice. Palate development
was normal in forebrain selective β3 knockout mice. These knockouts survived the neonatal
period, but ~30% died between 15–25 days of age. Survivors had reduced reproductive fitness,
reduced sensitivity to etomidate, were hyperactive, and some became obese.
Conclusion: Conditional inactivation of the β3 gene revealed novel insight into the function of this
GABAA-R subunit. The floxed β3 knockout mice described here will be very useful for conditional
knockout studies to further investigate the role of the β3 subunit in development, ethanol and
anesthetic action, normal physiology, and pathophysiologic processes.
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Background
γ-aminobutyric acid (GABA), acting via GABA type A
receptors (GABAA-Rs), mediates the bulk of rapid inhibi-
tory neurotransmission in the adult mammalian central
nervous system. GABAA-Rs are pentameric chloride chan-
nels assembled from 19 different subunits, α 1–6, β1–3,
γ1–3, δ, ε, π, ρ1–3, and θ[1]. Most native receptors are
formed from 2α, 2β, and 1γ or 1δ subunits [2].
The β3 subunit is especially interesting because this subu-
nit has been suggested to be a candidate gene for neurode-
velopmental disorders such as Angelman Syndrome [3-5]
and autism spectrum disorder [6-8]. β3 containing
GABAA-R isoforms also are a crucial site of action for intra-
venous anesthetics [9-11] and ethanol [12], and an
important receptor involved in developmental processes
[13,14].
The  β3 subunit is widely expressed in the developing
rodent brain and spinal cord [15]. In the adult rodent,
highest levels of β3 expression are restricted to hippocam-
pus, cortex, olfactory bulb striatum, and lower levels are
observed in numerous other brain regions [16,17].
To elucidate the role of the β3 subunit in physiology and
pathophysiology, we previously created and characterized
a mouse line that harbored a null allele of the β3 subunit
[18]. These global knockout mice ubiquitously lacked the
β3 protein throughout development in the whole animal.
High levels of neonatal mortality [18] and compensatory
adaptations were observed [19,20] that limited the utility
of the model. To overcome the shortcomings of the global
β3 knockout model, we have now successfully created a
mutant β3 mouse line that can be used to create tissue-
specific and/or developmentally regulated β3 knockouts.
Here, the production and characterization of the condi-
tional knockout model, and the use of this model to gain
new insight into the role of β3 containing GABAA-Rs in
development, behavior, body weight control, and anes-
thetic action is described.
Results
Gene targeting
A gene targeting construct (see Figure 1) was introduced
into mouse embryonic stem cells to modify the β3 locus.
A total of 91 embryonic stem cell clones were screened by
Southern blot analysis to identify correctly targeted
clones. Eight clones were correctly targeted. Gene target-
ing at the β3 locus created an EcoRV restriction fragment
length polymorphism; a 3' probe that was external to the
targeting construct hybridized to a 17.1 kb fragment from
the wild type allele (designated β3+) and to a 13.9 kb frag-
ment from a correctly targeted allele (designated as β3Fneo;
see Figure 1). Retention of the 5' loxP site was verified by
the presence of a 2.1 kb BglII restriction fragment that
hybridized to the β3–10 probe. Correctly targeted clones
were analyzed with several additional enzymes and
probes and all results were consistent with targeting at the
β3 locus (data not shown).
Of 4 correctly targeted clones injected into mouse blasto-
cysts, chimeric mice from 2 clones transmitted the tar-
geted β3 allele to the F1 generation following mating to
C57BL/6J females. The results presented here were derived
from clone 77S8.
The unrecombined floxed β3 gene functioned normally
Heterozygous (β3+/Fneo) F1 mice were mated to an actin-
FLPe transgenic deleter mouse line [21] to remove the neo
gene by FLPe-mediated site-specific recombination. This
produced mice that were heterozygous for the wild type
and the floxed (flanked by loxP sites) β3 alleles and lacked
the neo gene (β3+/F). These mice were interbred to pro-
duce wild type (β3+/+), heterozygous (β3+/F) and
homozygous floxed (β3F/F) mice. β3F/F mice were born at
the expected frequency, were viable, did not have cleft pal-
ate, and were overtly indistinguishable from control litter-
mates. This is in direct contrast to mice with global
disruption of the β3 gene [3,14,18]; most of these mice
died as neonates, had cleft palate, and those that survived
had multiple behavioral abnormalities. Thus, the floxed
β3 gene did not grossly have an adverse effect on function
of the β3 gene.
The recombined β3 gene is a null allele
β3+/F mice were subsequently crossed to an actin-cre trans-
genic deleter mouse line [22] to recombine the floxed β3
allele and delete exon 3. Deletion of this 68 basepair exon
was predicted to create a frameshift mutation and intro-
duce a premature stop codon. The predicted product of
the mutant β3 allele contains amino acids 1–58 of β3 fol-
lowed by a novel 13 amino acid sequence. This product,
which is devoid of the amino terminal 415 amino acids
(β3 protein is normally 473 amino acids in length),
should produce a nonfunctional product as all four of the
putative transmembrane domains would be absent. Mice
that were heterozygous for the cre recombined allele (β3+/
F) were interbred to produce β3+/+, β3+/F, and homozygous
recombined (β3F/F) mice. While the frequency of β3F/F off-
spring was close to that expected by Mendelian genetics
[actual 11 of 61 (18%) vs expected frequency of 25%], 10
of the 11 offspring died 2 days postnatally and the survi-
vor at day 21. Fifty-four percent (6 of 11) of these mice
had cleft palate. These results were consistent with the
phenotype of global β3 knockouts that were produced by
traditional gene targeting [18]. Thus, the recombined β3
allele functioned as a null allele following cre-mediated
recombination.BMC Neuroscience 2007, 8:85 http://www.biomedcentral.com/1471-2202/8/85
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Production and analysis of pan-neuronal β3 knockout 
mice
Floxed β3 mice were also crossed to a synapsin I-cre (Syn-
cre) transgenic mouse line [23,24] to produce neuron-
specific conditional knockout mice. This cre expressing
mouse line induces widespread recombination exclu-
sively in neurons starting at embryonic day 12.5.
To investigate the effects of embryonic, pan-neuronal
knockout of β3, pups were collected before birth (embry-
onic day 17.5–20.5) from β3F/F, cre- by β3F/F, cre+ mating
pairs for genotype analysis. This study revealed that β3F/F,
cre+ pups were present at a frequency that was similar to
β3F/F, cre- pups (28/53 and 25/53, respectively). Visual
analysis of the palates of a subset of these mice revealed
that 0 of 9 β3F/F, cre+ pups examined in detail had cleft
palate. Thus, we conclude that pan-neuronal knockout of
β3 is compatible with in utero survival and normal palate
development.
To investigate the effects of pan-neuronal knockout of β3
on postnatal survival and development, a genotypic anal-
ysis of weanling mice derived from β3F/F, cre- by β3F/F,
cre+ mating pairs was performed. This study revealed that
only ~28% (108/384) of the mice genotyped were cre+, in
contrast to the ~72% (276/384) that were cre-. This differs
from the expected 1:1 ratio. These results suggest that
~61% of the β3F/F, cre+ mice died before weaning. Many
Gene targeting strategy Figure 1
Gene targeting strategy. Diagram of the wildtype β3 locus illustrating the first three exons (orange boxes) and surrounding 
genomic DNA (thin, black line). Also shown are the DNA probes (yellow boxes) that were used for Southern blot analysis. 
The targeting construct included a neomycin (neo) cassette that was flanked by two frt sites (blue triangles), two loxP sites 
(red triangles), a thymidine kinase (TK) cassette, and plasmid vector backbone (broken, wavy line). During vector construction, 
the BglII restriction sites shown in grey lettering were destroyed. Also shown is a correctly targeted locus (Fneo), a locus fol-
lowing FLPe mediated deletion of the neo cassette (F), and a locus following Cre mediated deletion of exon 3 (f). Abbrevia-
tions: BamHI, B; BglII, Bg; EcoRV, RV.
2 3
TK Neo
B RV Bg
Wild Type
(+)
Targeting
Construct
Targeted
(Fneo)
17.1 kb
9.7 kb
FLPe Recombined
(F)
Cre Recombined
(f)
Bg B BB RV
2 3
B RV Bg Bg B B B
1
1
Neo 2 3
B RV Bg Bg B B B
1
RV
Bg
Bg
Bg
Bg
B
B
2 3
B RV Bg Bg B B B
1
RV
Bg
2
B RV Bg Bg B B
1
RV
Bg
2.1 kb 3.4 kb
3' external
probe
p 3
probe
 3-10
probe
RV
B
13.9 kb
B
3.6 kb
3.1 kb
5.9 kb
5.9 kb
5.9 kbBMC Neuroscience 2007, 8:85 http://www.biomedcentral.com/1471-2202/8/85
Page 4 of 13
(page number not for citation purposes)
of the cre+ pups died within a few days of birth. Thus, we
conclude that pan-neuronal inactivation of β3 by Syn-cre
appears to result in a variably penetrant, non-cleft palate,
neonatal lethality.
Gross behavior of the β3F/F, cre+ mice that survived
beyond weaning were observed while in their home cage
and during handling. The cre+ mice were overtly indistin-
guishable from control, cre- littermates. Unlike the global
β3 knockouts [3,18], these conditional β3 knockouts did
not display foot clasping behavior, hyperactivity, seizures,
or tremors. In addition, both sexes of β3F/F, cre+ mice were
found to be fertile and females displayed normal maternal
care.
To examine the degree to which the β3 gene product was
reduced in various brain regions of the knockouts, west-
ern blot analysis of hippocampus, cortex, and cerebellum
was performed using a β3 specific antibody. As shown in
Figure 2, Syn-cre mediated knockout of β3 resulted in a
dramatic reduction of β3 protein in all brain regions
examined.
Pan-neuronal knockout mice were tested for sensitivity to
the intravenous anesthetic etomidate and ethanol using
the standard loss of the righting reflex (LORR) assay. For
etomidate, the analysis revealed a significant effect of gen-
der (p < 0.01). Therefore, males and females were ana-
lyzed separately. This gender difference was also seen
when etomidate was administered intravenously (data
not shown). As shown in Figure 3A, both male and female
knockouts were less sensitive to the sedative/hypnotic
effects of etomidate as evidenced by the reduced duration
of the LORR as compared to controls (p < 0.05). There was
no effect of gender on ethanol-induced sleep time. There-
fore, data were collapsed and analyzed together. Ethanol-
induced sleep time did not differ between genotypes (Fig-
ure 3B).
Production and analysis of forebrain selective β3 knockout 
mice
To produce a β3 knockout that is restricted only to post-
natal forebrain neurons, the floxed β3 mice were crossed
with an α CamKII-cre mouse line [25]. This mouse line
has been reported to restrict recombination specifically to
pyramidal neurons of the CA1 region of the hippocampus
Western blot analysis of pan-neuronal β3 knockouts Figure 2
Western blot analysis of pan-neuronal β3 knockouts. Western blot analysis of the β3 subunit of the GABAA-R from 
individual 7–9 week old mice revealed dramatically reduced amounts of β3 in hippocampus (A), cortex (B) and cerebellum (C) 
of Syn-cre positive samples compared to cre negative control samples. All blots were reprobed for β-actin as a loading control. 
Shown are representative western blots. Five mice of each genotype were analyzed and all samples were analyzed on at least 
two different blots. D. Summary graph of western blot analysis demonstrating a significant (*, p < 0.05;**, p < 0.01) reduction in 
β3 protein in all brain regions examined. Data are expressed as mean ± SEM of percent change in band intensity relative to cre 
negative controls following normalization to actin.BMC Neuroscience 2007, 8:85 http://www.biomedcentral.com/1471-2202/8/85
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starting ~2 weeks after birth [25]. In a complementary
report, a slightly broader pattern of recombination,
deemed as "forebrain selective", that included the amy-
gdala and cortex in addition to the hippocampus was
described [26].
Mating of β3F/F, cre- by β3F/F, cre+ produced normal sized
litters with no apparent neonatal mortality. However,
some cre+ mice died between 15 and 25 days after birth,
a time frame that coincides with expression of cre recom-
binase from the α CamKII-cre mouse line [25]. General
observation of these mice discovered no abnormal pheno-
type, but interestingly, of 39 cre+ mice that died prema-
turely, 72% were male. At 4 weeks old, genotype analysis
of surviving offspring revealed a ~30% reduction in cre+
mice (121/294) compared to cre- (173/294). Some of the
cre+ mice that survived beyond weaning exhibited abnor-
mal neurological behavior. These mice tended to be
hyperresponsive to human contact, and at times appeared
to be 'frozen' in their home cage, possibly having absence
seizure-like behavior. This phenotype appeared to worsen
with age and is similar to that observed in global β3
knockout mice [3].
To examine the impact of α CamKII-cre mediated recom-
bination on the β3 gene product, western blot analysis
was conducted on hippocampus, cortex, cerebellum, and
hypothalamus using a β3 specific antibody. As shown in
Figure 4, β3 protein was dramatically reduced in hippoc-
ampus and was nearly completely ablated in cortex of cre+
mice compared to cre- controls. In contrast, the amount of
β3 in cerebellum was not significantly reduced by the α
CamKII-cre transgene. Cortex from 4 week old mice was
also examined for the amount of β3. This analysis
revealed a ~50% reduction in β3 in forebrain selective
knockout mice compared to controls (Figure 4E).
Loss of righting reflex (LORR) assay Figure 3
Loss of righting reflex (LORR) assay. A. Etomidate-induced LORR in pan-neuronal knockout mice was dependent on gen-
der (p < 0.01). Therefore, male and female mice were analyzed separately. Both male and female pan-neuronal β3 knockouts 
were less sensitive to the sedative/hypnotic effects of etomidate (20 mg/kg) as evidenced by the reduced duration of the LORR 
compared to same sex controls. B. Ethanol-induced (3.5 g/kg) LORR did not differ between controls and pan-neuronal β3 
knockouts. C. Etomidate-induced (20 mg/kg) LORR in forebrain selective β3 knockouts was not dependent on gender but 
knockouts were less sensitive compared to controls. D. Ethanol-induced (3.5 g/kg, i.p.) LORR of forebrain selective knockout 
mice did not differ compared to controls. *, p < 0.05; **, p ≤ 0.01.
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Reproductive fitness of β3F/F, cre+ mice was tested by
crossing to wild type mates. Both males and females were
reproductively impaired. Two of six females that were test-
mated consistently produced and cared for normal sized
litters. The four other females either did not produce any
offspring or produced litters infrequently and usually
failed to care for pups. Male β3F/F, cre+ mice were test
mated to superovulated females. None of the four cre+
mice produced copulation plugs, in contrast to 12 of 12
cre- mice that were tested for comparison. In addition,
these four cre+ mice were housed with β3F/+, cre- females
for 2–4.5 months. One male sired a seemingly normal
number of litters during that time (n = 4), whereas the
other three males each only sired a single litter. Thus, male
reproductive fitness also seemed to be compromised.
During the course of these studies, we also noticed that
some, but not all, β3F/F, cre+ became obese in adulthood.
To quantify this, the body weights of mice from 4–16
weeks of age were measured. As shown in Figure 5A, B,
cre+ mice attained significantly greater body weights by
~8–10 weeks of age compared to cre- controls. Further-
more, analysis of the distribution of body weights
revealed that there was considerable variability in the
body weights of the cre+ mice. For example, at 14 weeks
of age, while some cre+ animals had body weights that
overlaped with controls, others had body weights that
were 1.75× average control values (Figure 5C, D).
To find out if the obese mice also had a greater food
intake, food consumption between knockout males and
controls was compared. By 20 weeks of age, all surviving
cre+ males were obese (47.7 ± 2.0, g ± SEMfor KO's vs.
Western blot analysis of forebrain selective neuronal β3 knockouts Figure 4
Western blot analysis of forebrain selective neuronal β3 knockouts. Western blot analysis of the β3 subunit of the 
GABAA-R from individual 13–16 week old mice revealed dramatically reduced amounts of β3 in hippocampus (A) and cortex 
(B) of α CamKII-cre positive samples compared to cre negative control samples. The amount of β3 in cerebellum (C) did not 
differ between genotypes. Analysis of cortex for the GABAA-R α1 subunit revealed a ~95% reduction in knockout samples 
compared to cre negative controls. All blots were reprobed for β-actin as a loading control. Shown are representative western 
blots. Four mice of each genotype were analyzed and all samples were analyzed on at least two different blots. D. Summary 
graph of western blot analysis demonstrating a significant (*, p ≤ 0.01; **, p < 0.001) reduction in β3 protein in hippocampus 
and cortex, but not in cerebellum. Data are expressed as mean ± SEM of percent change in band intensity relative to cre nega-
tive controls following normalization to actin. (E) Western blot analysis of β3 in cortex from individual 4 week old mice 
revealed dramatically reduced amounts of β3 in cre positive samples compared to cre negative control samples.BMC Neuroscience 2007, 8:85 http://www.biomedcentral.com/1471-2202/8/85
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Body weight and food consumption analyses of forebrain selective β3 knockouts Figure 5
Body weight and food consumption analyses of forebrain selective β3 knockouts. Growth curves of (A) male and 
(B) female mice (n = 4–12 mice of each gender per genotype at each age). Body weight of knockout mice was greater than con-
trols (repeated measures ANOVA: p < 0.01 for males; p < 0.05 for females). Plotted are means ± SEM. For data points without 
error bars, the bars are obscured by the symbol. Body weight of individual (C) male and (D) female mice at 14 weeks of age. 
The horizontal line indicates the group mean. Male and female knockouts were heavier than controls (p ≤ 0.05). Note the great 
variability in the body weight of knockout mice, including several obviously obese male animals that are ~1.75× heavier than 
controls. (E) Obese forebrain selective male knockout mice consumed more food than controls (*, p < 0.05). Shown is the 
average daily consumption per mouse ± SEM.
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33.9 ± 1.8 for controls). Average food consumption
assessed over the course of 8 days was greater in knock-
outs compared to controls (p < 0.05; Figure 5E).
The forebrain selective knockout mice were also tested for
sensitivity to etomidate and ethanol. No effect of gender
was observed in either assay. As shown in Figure 3C,
knockouts were less sensitive to the sedative/hypnotic
effects of etomidate compared to controls (p ≤ 0.01). In
contrast, ethanol-induced sleep time did not differ
between genotypes (Figure 3D).
Spontaneous locomotor activity testing revealed that fore-
brain selective knockout mice were more active than the
Cre- control mice as evidenced by the greater total activity
of knockouts (p < 0.05; Figure 6A). When only the ambu-
latory component of the total activity measurement was
isolated for separate comparison, there was a trend for
knockouts to exhibit greater activity (p = 0.067). During
locomotor assessments mice were also closely observed
for any indication of convulsive or absence-like behavior.
No convulsive like behaviors were observed during test-
ing, however one mouse was observed to have a convul-
sive seizure on a later date.
Mice were tested for learning and memory using a passive
avoidance assay. As shown in Figure 6B, time to re-enter
the dark side of the test apparatus was significantly
increased by an aversive footshock (p < 0.0001). How-
ever, there was no effect of genotype or interaction of gen-
otype with shock.
Discussion
In this study a novel genetically engineered mouse line
that was used to create GABAA-R β3 subunit conditional
gene knockout mice was developed. This mouse line
allowed further assessment of the involvement of the β3
GABAA-R subunit in formation of the palate, viability,
body weight regulation, behavioral responses, and seda-
tive/hypnotic drug sensitivity. Results are summarized
and compared to global β3 knockouts in Table 1.
Cre recombinase mediated global knockout of β3 resulted
in a high frequency (~55%) of cleft palate. This result
agrees with studies that have reported a high frequency of
cleft palate in mice that lack β3 due to traditional knock-
out of β3 [18] or radiation-induced deletion of β3 [27].
Furthermore, it has been demonstrated that ubiquitous
expression of β3 alone on a β3 deficient background is
sufficient to rescue this phenotype [14].
While these global knockout/transgenic studies clearly
define a role for β3 in normal palate formation, they do
not distinguish between a neuronal and nonneuronal site
of action. To dissect the contribution of neuronal vs non-
neuronal β3 in palate formation, a conditional knockout
Behavioral responses of forebrain selective β3 knockouts Figure 6
Behavioral responses of forebrain selective β3 knockouts. A. Spontaneous locomotor activity was measured and 
expressed in arbitrary units over a 10 min assessment period. Forebrain selective knockout mice were found to exhibit a sta-
tistically significant increase in total activity compared to cre- control mice. When the ambulatory component of total activity 
was examined, there was a trend for increased activity (p = 0.067). B. Passive avoidance. Shown is the latency to enter the dark 
side of the test apparatus expressed as the difference in latency between day 2 and day 1. Mice were exposed to a mild foot-
shock (0.4 mA, 3 sec) on day 1. Separate groups of animals were also tested under identical conditions except they did not 
receive the footshock on day 1. Footshock increased the latency to enter (p ≤ 0.0001), but genotype and the interaction of 
genotype with footshock were not significant. *p < 0.05
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mouse line which lacked β3 in most neurons was devel-
oped. In these pan-neuronal knockout mice, cre-mediated
recombination was under the control of the rat synapsin I
promoter. Although the time course of cre-mediated inac-
tivation of β3 in these mice was not examined in detail,
this same Syn-cre transgenic mouse line has been demon-
strated to induce recombination primarily in neurons of
the central nervous system starting at approximately
embryonic day 12.5 [23,24]. Cleft palate was not
observed in this mouse line. These results lead us to sug-
gest that neuronal β3 is not required for normal palate for-
mation. This is consistent with the conclusions derived
from a study where β3 was expressed only in neurons on
a β3 knockout background [28]. That study demonstrated
that neuronal expression of β3 was unable to rescue the
animals from the clefting defect. Together, these results
lead us to suggest, but do not prove, that GABAergic sign-
aling through β3 containing GABAA-Rs in nonneuronal
tissues is critical for normal development of the palate. An
alternative explanation is that the time course and/or the
extent of the genetic modification in the present study or
in the study of Hagiwara et. al [28] was not sufficient to
modulate palate formation. Thus, an obligate neuronal
requirement of β3 for normal palate formation cannot be
excluded. Continued investigation of β3's role in palate
formation is warranted as the β3 locus has been impli-
cated in human clefting defects [29].
The results presented here also shed new light on the
requirement of β3 for normal viability. Global deletion of
β3 resulted in a very high frequency of neonatal mortality,
a result that is consistent with earlier studies of global β3
knockouts [18,27]. These results confirm that β3 is not
required for survival in utero but is required for the transi-
tion to life immediately after birth. A high level (~61%) of
perinatal mortality in pan-neuronal β3 knockouts was
observed. The fact that pan-neuronal knockout did not
result in cleft palate indicates that the perinatal mortality
is not due to a defect in the palate that prevents feeding.
The cause of death in these animals has not been deter-
mined. Furthermore, forebrain selective deletion of β3
(initiated ~2 weeks after birth) rescues the mice from peri-
natal mortality, but it fails to ensure survival to adult-
hood. Approximately 30% of forebrain selective β3
knockout mice die between 2 and 4 weeks of age. These
results reveal that neuronal β3 is required beyond the
perinatal period for normal viability. Furthermore, these
results confirm that the mortality is not due to aberrant
embryonic development. Instead, we conclude that there
is a role for β3 in neuronal function that is required for
survival.
Those conditional β3 knockouts that survived to adult-
hood displayed a variety of abnormalities that varied con-
siderably between animals. Forebrain selective deletion of
β3 also resulted in deficits in reproductive fitness, mater-
nal care, and overt behavior. These phenotypes were sim-
ilar to that observed in global β3 knockouts [3,14,27].
Hyperactivity is a common observation in global β3
knockout mice [3,18]. Although forebrain selective β3
knockout mice were not observed to be nearly as hyperac-
tive as global knockouts, they exhibited a statistically sig-
nificant increase in their total activity, compared to
Table 1: Comparison of phenotypic abnormalities observed in gene targeted β3 gene knockout mice
Phenotype Global knockout Pan-neuronal knockout* Forebrain selective knockout*
Time course of gene inactivation Embryonic day 0 [18] ~Embryonic day 12.5+ ~2 weeks postnatal
Tissue specificity All cells [18] Most neurons Primarily forebrain neurons
Viability ~90% die as neonates [18] ~61% die as neonates ~30% die at 15–25 days of age
Palate ~55% with cleft [18]* Normal Normal
Overt behavior Hyperactive; hyperresponsive [3, 18] Normal Moderate hyperactivity; jumpy
Locomotor activity Increased [3] Not tested Increased
Motor coordination Impaired [3] Not tested Not tested
Seizure-like activity Multiple seizure types [3] None observed Occasional absence-like and convulsive 
seizures
EEG Abnormal [3, 18] Not tested Not tested
Foot clasping Present [18] Absent Absent
Fertility Normal [18] Normal Reduced
Maternal behavior Impaired [18] Normal Impaired
Body size Runted until weaning but most attain 
normal size by adulthood [18]
Normal Some become obese
Food intake Not tested Not tested Increased
Etomidate LORR Reduced [33] Reduced Reduced
Ethanol LORR Normal [33] Normal Normal
Learning and memory Impaired [3] Not tested Normal
Rest-activity cycles Disturbed [3] Not tested Not tested
*, results from present study.BMC Neuroscience 2007, 8:85 http://www.biomedcentral.com/1471-2202/8/85
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control mice (Figure 6A). As previous studies on global β3
knockout mice found them to exhibit high baseline veloc-
ities and ambulation [3], these experiments were designed
to likewise separate out the ambulatory component of the
total activity measurements on the conditional knock-
outs. Subsequently, there was a trend for ambulatory
activity to be higher in forebrain selective β3 knockouts
compared to cre- controls. This observation is evidence
that locomotor components other than ambulation
strongly impacted the resultant total activity measure-
ments taken on the forebrain selective knockout mice. For
example, the conditional knockouts, compared to con-
trols, may have focused more on locomotor activities
related to rearing, grooming or exploring small regions of
the test apparatus rather than participating in higher
ambulatory activity.
Body weights were increased by forebrain selective knock-
out of the β3 subunit in both male and female mice (Fig-
ure 5). This may have been due in part, at least in the
males, to an increase in food intake and occurred despite
an increase in locomotor activity. It is of interest to note
that the response in both males and females was variable,
with only a subset of animals showing a clear increase in
weight. This is most likely due to the fact that animals in
this study were of a mixed background. Given the large
body of literature showing GABA or GABAA-R agonists to
be stimulators of food intake [30], the increase in body
weight was somewhat unexpected. It may be that deletion
of the β3 subunit resulted in a compensatory GABAA-R
response that increased the functional activity of GABAA-
Rs in brain areas involved in regulating food intake, e.g.,
the hypothalmus. However, the role of GABA in the
mechanisms governing food intake and body weight is
unclear. GABA has been shown to be colocalized with
neuropeptide-Y neurons in the arcuate nucleus of the
hypothalamus [31] which contact and inhibit arcuate
proopiomelanocortin neurons [32] that suppress food
intake. We have observed that β3 is reduced ~50% in the
hypothalamus of forebrain selective knockouts (data not
shown). However, GABAA-R-containing neurons in the
lateral parabrachial nucleus of the brainstem have also
been postulated to be involved in GABA-mediated
increases in food intake [30]. While GABA is clearly
involved in regulating body weight, the ubiquitous nature
of GABA in the brain makes determining the mechanisms
involved difficult. The ability to manipulate expression of
a predominant GABAA-R subunit in an anatomically-spe-
cific manner is an important first step in unraveling the
role of GABA in regulating body weight.
A previous study revealed that global β3 knockout mice
were less sensitive to the sedative/hypnotic effects of eto-
midate [33]. However, because of the ubiquitious nature
of the β3 knockout, developmental compensation was
observed [20] that made it impossible to determine if the
reduction in anesthetic sensitivity was due to deletion of a
direct target of etomidate or due to a compensatory
change in an unknown target. In the current study, we
demonstrated that inactivation of β3 selectively in fore-
brain neurons after ~2 weeks of postnatal life also resulted
in reduced sensitivity to the sedative/hypnotic response to
etomidate. This result, together with results derived from
gene knockin studies [9,11] lead us to suggest that β3, and
not a compensatory change in an unknown target, is a
direct target for some of the anesthetic effects of etomi-
date.
Reportedly, β3 containing GABAA-Rs are also important
for mediating the effects of ethanol [12]. However, the
sedative/hypnotic effect of ethanol was not changed by
conditional (Figure 3B, D) or global inactivation [33] of
the β3 gene. Thus, the β3 subunit is not necessary for the
sedative/hypnotic effect of ethanol. Other behavioral
effects of ethanol (e.g., motor incoordination, cognative
impairment, etc.) remain to be tested in these mice.
It is unknown why the cleft palate, mortality, body weight,
and behavioral phenotypes are variably penetrant within
the various β3 mutant mouse lines. It is possible that ani-
mal-to-animal variability exists because of genetic hetero-
geneity in the background of the animals. None of the
mutant mouse lines used here were maintained on a uni-
form, inbred genetic background. Genetic background
has been demonstrated to substantially alter the incidence
of cleft palate in global β3 knockouts [28]. Detailed inves-
tigation of β3 mutants maintained on a hybrid genetic
background could be used to search for modifier genes
that interact with the GABAergic system in palate develop-
ment (and possibly in the other observed phenotypes).
Alternatively, a possibility exists that those β3 mutant ani-
mals that escaped from palate defects and neonatal mor-
tality were able to invoke a compensatory pathway to
overcome the genetic defect. Indeed, global knockouts
exhibited substantial compensatory responses [19,20].
Although deletion of β3 after birth would circumvent
developmental compensation during early development,
it is still possible (actually quite likely) that compensation
also occurred in those mice. For example, we have
observed that in the cortex of the forebrain selective
knockouts, the amount of the α1 subunit of the GABAA-R
was also reduced (Figure 4B). It is not clear if this is truly
a compensatory change or if it reflects an obligate subunit
partnership of β3 with α1 in this brain region. Nonethe-
less, while conditional knockout mice may circumvent
some issues observed in global knockouts such as com-
pensation during embryonic development, the condi-
tional knockout approach is not without limitations.BMC Neuroscience 2007, 8:85 http://www.biomedcentral.com/1471-2202/8/85
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The new line of genetically engineered mice described in
this report, i.e., mice with a floxed β3 gene, will be inval-
uable for a wide variety of studies. As demonstrated in the
current study, knockout of β3 by the traditional method
of crossing the floxed mice to a cre recombinase express-
ing transgenic mouse can be used to make tissue specific
and/or temporally regulated conditional knockouts.
Addition of a regulated cre recombinase, such as cre-ER
that is regulated by tamoxifen [34], would provide even
greater temporal control over the conditional nature of
the knockout. The floxed β3 mice will also be useful for
nontraditional methods of creating conditional knock-
outs such as stereotaxic microinjection of cre expressing
viral vectors [35] or in vivo electroporation of cre express-
ing plasmids [36]. This wide variety of approaches for pro-
ducing mice that conditionally lack β3 will open up new
avenues for investigating the role of β3 in normal physiol-
ogy and pathophysiology.
Conclusion
A mutant mouse line that harbors a floxed β3 subunit of
the GABAA-R was successfully produced. Pan-neuronal
and forebrain selective knockout of β3 revealed new
insight into the role of the β3 subunit in palate formation,
embryonic and postnatal viability, behavior, body weight
regulation, and etomidate sensitivity. The floxed β3 mice
described in this report will be very useful for conditional
knockout studies to further investigate the role of the β3
subunit of the GABAA-R in various developmental proc-
esses, normal physiology, and pathophysiologic disorders
such as Angelman syndrome and autism spectrum disor-
der.
Methods
Gene Targeting
A gene targeting DNA construct was prepared from Strain
129/SvJ mouse genomic DNA. This construct contained
~9.7 kb of mouse genomic DNA from the β3 locus, a loxP
site inserted into intron 2, a neomycin selectable marker
gene from pK-11 [22] that was flanked by two frt sites and
a single loxP site (all inserted into intron 3), and the MC1-
thymidine kinase gene [37]. The 5' loxP site was intro-
duced into a novel BglII restriction site that was added to
intron 2 by site directed mutagenesis (MORPH Mutagen-
esis Kit, 5 Prime-3 Prime, Inc., Boulder, CO). The neomy-
cin cassette replaced a 321 bp BamHI fragment in intron
3. This construct was linearized with NotI and electropo-
rated into R1 [38] embryonic stem cells as previously
described [39]. Cells that survived G418 (265 μg/ml; Inv-
itrogen) and ganciclovir (2 μM) selection were analyzed
for gene targeting by Southern blot analysis. Correctly tar-
geted clones were injected into C57BL/6J blastocysts to
produce chimeric mice. Chimeras were mated to C57BL/
6J mice to produce F1 animals that harbored the modified
β3 locus. All animal studies followed the Guide for the
Care and Use of Laboratory Animals and were approved
by Institutional Animal Care and Use Committee's.
Production of β3 Global Knockout Mice
Mice harboring the targeted, neo-containing floxed β3
locus were crossed to an actin-cre deleter mouse line (FVB
X C57BL/6J background) [22] to produce a cre recom-
bined β3 allele in all cells. Mice heterozygous for the cre
recombined allele were interbred to produce wild type,
heterozygous, and homzogyous global knockout mice.
Production of β3 Conditional Knockout Mice
Mice harboring the neo-containing floxed β3 locus were
crossed to an actin-FLPe deleter mouse line [21] to perma-
nently and specifically delete the neo selectable marker
from the β3 locus. The actin-FLPe mice originated on a
B6SJLF2 genetic background but were backcrossed to
C57BL/6J for 3 generations. Following FLPe-mediated
deletion of the neo cassette from the β3 locus, the actin-
FLPe transgene was bred out of the pedigree by backcross-
ing to C57BL/6J for one additional generation. Mice that
were heterozygous for the floxed β3 locus without the neo
gene were subsequently mated to Syn-cre [23,24] or α
CamKII-cre (line T29-1) [25] transgenic mice to produce
conditional β3 knockouts. Syn-cre mice were a gift of J.
Marth (UCSD) and were received on a C57BL/6NHsd
background that was backcrossed one generation to
C57BL/6J. αCamKII-cre mice originated in the lab of S.
Tonegawa (MIT) and were maintained in our lab on a
C57BL/6J × Strain 129Sv/SvJ background.
Western blot analysis
Protein levels in various brain regions of pan-neuronal
and forebrain selective knockouts were analyzed using
semi-quantitative Western blotting as described [40].
Briefly, cerebellum, cortex, and hippocampus were dis-
sected and flash-frozen on dry ice. P2 membrane fractions
were isolated and 25 ug of each sample was analyzed.
Each sample (n = 4–5 samples/genotype) was analyzed on
at least 2 different blots. Blots were sequentially probed
with anti-β3 (NB300-119; Novus Biologicals, Littleton,
CO) and anti-β-actin polyclonal (ab8227-50; Abcam,
Cambridge, MA) antibodies. The actin signal was used to
normalize for loading differences. Blots of cortex from
forebrain selective knockouts and controls were also ana-
lyzed for GABAA-R  α1 using an α1 specific antibody
(Upstate, Lake Placid, NY). Primary antibodies were
detected with HRP-conjugated goat anti-rabbit antibody
(Novus Biolgicals) and visualized by chemiluminesence
(Western Lightning, PerkinElmer Life and Analytical Sci-
ences, Boston, MA). Immunoreactive protein levels were
compared by densitometric measurement of band inten-
sities and analyzed using Student's t test.BMC Neuroscience 2007, 8:85 http://www.biomedcentral.com/1471-2202/8/85
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Body weight and food consumption
Mice were individually weighed at weekly intervals
between 4 and 16 weeks of age. Data were analyzed by
repeated measures ANOVA.
Food consumption was determined on singly-housed 20
week-old male mice by weighing the amount of food con-
sumed during an eight day period. The average daily food
consumption (in grams) was calculated and data were
analyzed using a Student's t test.
Behavioral analysis
Adult forebrain selective and pan-neuronal knockout and
control mice were tested for sensitivity to ethanol or the
anesthetic etomidate using a standard sleep time assay as
described [39]. Briefly, mice were injected with 3.5 g eth-
anol (Pharmco, Brookfield, CT) or 20 mg etomidate (Bed-
ford Laboratories, Bedford, OH) per kg body weight into
the intraperitoneal cavity. When mice lost the righting
reflex, they were placed in v-shaped troughs and the time
until they were able to right themselves three times within
30 sec was recorded. Sleep time was defined as the dura-
tion of the loss of the righting reflex. Differences between
genotypes were determined using a t-test. Because of the
limited number of mice available for this study, both
males and females were used.
Operant learning was assessed using a step-through pas-
sive avoidance task as previously described in detail [41].
Briefly, a TruScan activity monitor (Coulbourn Instru-
ments, Allentown, PA) that included a removable Plex-
iglas insert was used. The insert divided the test arena into
light and dark chambers. The floor of the test apparatus
was made of steel rods that were used to deliver a foot-
shock. Mice were placed in the lighted chamber and the
time to enter the dark side was recorded. Upon entering
the dark chamber, the mice were delivered a mild foot-
shock (0.4 mA, 3 sec), removed from the test apparatus,
and returned to their home cage. Twenty-four hours later,
the procedure was repeated except that no shock was
delivered. The latency to enter the dark chamber was cal-
culated as the difference in latency between day 2 and day
1. Separate groups of mice were treated exactly as
described except they did not receive a footshock upon
entering the dark chamber. These mice were referred to as
the "no shock" group. Data were analyzed by ANOVA.
Spontaneous locomotor activity was assessed using an
automated open field test apparatus. Mice were allowed to
acclimate to the test room for 30 min prior to testing. Mice
were placed individually into clear plastic monitoring
chambers measuring 72 × 32 × 32 cm. Locomotor activity
was measured via seven sets of photoelectric sensors
evenly spaced along the length of the monitoring cham-
ber, 4 cm above the floor of the chamber (San Diego
Instruments, San Diego, CA). Total activity was recorded
in arbitrary units reflective of the number of times a
mouse interrupted the photoelectric sensors during a 10-
min monitoring session. Data was automatically recorded
and stored by computer. Data was collected in two bins,
one representing the total activity and the other represent-
ing the ambulatory component of total activity. Total
activity includes ambulatory activity as well as locomotor
activities directed towards rearing, grooming and explor-
ing small regions of the testing chamber. Data were ana-
lyzed by an unpaired Student's t-test using the software
program PRISM 4 (GraphPad Software, San Diego, CA).
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